TRCT
VET icon

Tower Research Capital (TRC)’s Vermilion Energy VET Stock Holding History

Tower Research Capital (TRC)’s Portfolio VET Stock Details VET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$145K Buy
10,523
+1,002
+11% +$10.6K ﹤0.01% 1880
2025
Q4 		$79.4K Sell
9,521
-6,388
-40% -$52.7K ﹤0.01% 2105
2025
Q3 		$124K Buy
15,909
+9,459
+147% +$73.1K ﹤0.01% 1829
2025
Q2 		$47K Buy
6,450
+4,136
+179% +$28.2K ﹤0.01% 3028
2025
Q1 		$18.7K Buy
+2,314
New +$20.7K ﹤0.01% 3035
2024
Q4 		– Sell
-2,402
Closed -$23.5K – 6021
2024
Q3 		$23.5K Sell
2,402
-4,832
-67% -$49K ﹤0.01% 3150
2024
Q2 		$79.6K Buy
7,234
+6,388
+755% +$75.9K ﹤0.01% 2751
2024
Q1 		$10.5K Sell
846
-11,295
-93% -$127K ﹤0.01% 3688
2023
Q4 		$146K Buy
12,141
+11,397
+1,532% +$151K ﹤0.01% 2340
2023
Q3 		$10.9K Sell
744
-3,618
-83% -$50.9K ﹤0.01% 4066
2023
Q2 		$54.4K Buy
4,362
+2,170
+99% +$26.8K ﹤0.01% 2516
2023
Q1 		$28K Sell
2,192
-7,796
-78% -$110K ﹤0.01% 3082
2022
Q4 		$177K Buy
+9,988
New +$203K 0.01% 1386
2022
Q3 		– Sell
-3,833
Closed -$73K – 6524
2022
Q2 		$73K Sell
3,833
-7,504
-66% -$156K ﹤0.01% 2542
2022
Q1 		$238K Buy
11,337
+8,858
+357% +$157K ﹤0.01% 1606
2021
Q4 		$31K Sell
2,479
-14,452
-85% -$157K ﹤0.01% 3196
2021
Q3 		$166K Buy
16,931
+8,842
+109% +$64.7K ﹤0.01% 1983
2021
Q2 		$71K Sell
8,089
-9,540
-54% -$74.6K ﹤0.01% 2725
2021
Q1 		$127K Buy
17,629
+11,881
+207% +$73.4K ﹤0.01% 2396
2020
Q4 		$25K Sell
5,748
-31,861
-85% -$113K ﹤0.01% 3736
2020
Q3 		$88K Buy
37,609
+33,383
+790% +$131K ﹤0.01% 3242
2020
Q2 		$19K Sell
4,226
-1,170
-22% -$5.51K ﹤0.01% 3712
2020
Q1 		$17K Buy
5,396
+5,371
+21,484% +$59.9K ﹤0.01% 1802
2019
Q4 		$0 Sell
25
-44,924
-100% -$677K ﹤0.01% 4417
2019
Q3 		$749K Buy
44,949
+44,332
+7,185% +$770K 0.05% 394
2019
Q2 		$13K Buy
617
+351
+132% +$8.19K ﹤0.01% 2428
2019
Q1 		$7K Sell
266
-190
-42% -$4.66K ﹤0.01% 2896
2018
Q4 		$9K Sell
456
-8,520
-95% -$221K ﹤0.01% 2575
2018
Q3 		$297K Buy
8,976
+8,619
+2,414% +$288K 0.02% 761
2018
Q2 		$13K Buy
+357
New +$12.4K ﹤0.01% 2676
2018
Q1 		– Sell
-2,048
Closed -$93K – 3870
2017
Q4 		$93K Buy
2,048
+1,848
+924% +$64.4K 0.01% 909
2017
Q3 		$9K Sell
200
-10,419
-98% -$342K ﹤0.01% 3121
2017
Q2 		$436K Buy
10,619
+8,593
+424% +$295K 0.05% 235
2017
Q1 		$76K Sell
2,026
-5,137
-72% -$203K 0.01% 554
2016
Q4 		$303K Buy
7,163
+6,611
+1,198% +$270K 0.03% 488
2016
Q3 		$21K Sell
552
-163
-23% -$5.74K ﹤0.01% 1591
2016
Q2 		$23K Buy
715
+400
+127% +$12.8K ﹤0.01% 2126
2016
Q1 		$9K Sell
315
-576
-65% -$15.5K ﹤0.01% 2090
2015
Q4 		$24K Buy
891
+740
+490% +$23.3K ﹤0.01% 1120
2015
Q3 		$5K Buy
+151
New +$5.15K ﹤0.01% 2827
2015
Q2 		– Sell
-1,500
Closed -$80K – 5063
2015
Q1 		$80K Buy
1,500
+1,350
+900% +$59.3K 0.01% 1086
2014
Q4 		$9K Hold
150
– – ﹤0.01% 2259
2014
Q3 		$9K Sell
150
-51
-25% -$3.26K ﹤0.01% 2907
2014
Q2 		$14K Sell
201
-599
-75% -$39.9K ﹤0.01% 2106
2014
Q1 		$55K Sell
800
-863
-52% -$49.5K 0.01% 1020
2013
Q4 		$97K Buy
1,663
+63
+4% +$3.54K 0.02% 888
2013
Q3 		$91K Sell
1,600
-2,219
-58% -$119K 0.01% 1383
2013
Q2 		$187K Buy
+3,819
New +$190K 0.02% 278

Other funds holding VET

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LAII
LM Asset (IM) Inc Vancouver, British Columbia, Canada $192M AUM 105.88% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return

Tower Research Capital (TRC)'s VET Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Vermilion Energy (VET) stake by 11% in Q1 2026, buying an estimated $10.6K and bringing the position to 10,523 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #1880.

Tower Research Capital (TRC) first reported a position in VET in Q2 2013 and has held it in 48 quarters since. The position peaked at $749K in Q3 2019. 160 funds tracked by Wall St. Rank hold VET as of Q1 2026.

  • Tower Research Capital (TRC) held 10,523 shares of Vermilion Energy worth $145K as of Q1 2026.
  • Tower Research Capital (TRC) bought 1,002 Vermilion Energy shares in Q1 2026, an estimated $10.6K.
  • Vermilion Energy made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1880 holding.
  • Tower Research Capital (TRC) first reported a position in Vermilion Energy in Q2 2013 and has held it in 48 quarters since.
  • Tower Research Capital (TRC)'s Vermilion Energy position peaked at $749K in Q3 2019.
  • 160 funds tracked by Wall St. Rank held Vermilion Energy as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.